![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | No longer recruiting |
Unique ID issued by UMIN | UMIN000004394 |
Receipt No. | R000005253 |
Scientific Title | Prospective study of efficacy of prophylactic hemostasis for ulceration post endoscopic submucosal dissection of early gastric tumor. |
Date of disclosure of the study information | 2010/10/16 |
Last modified on | 2010/10/16 |
Basic information | ||
Public title | Prospective study of efficacy of prophylactic hemostasis for ulceration post endoscopic submucosal dissection of early gastric tumor. | |
Acronym | Efficacy of hemostasis post ESD. | |
Scientific Title | Prospective study of efficacy of prophylactic hemostasis for ulceration post endoscopic submucosal dissection of early gastric tumor. | |
Scientific Title:Acronym | Efficacy of hemostasis post ESD. | |
Region |
|
Condition | ||
Condition | Early gastric cancer and adenoma | |
Classification by specialty |
|
|
Classification by malignancy | Malignancy | |
Genomic information | NO |
Objectives | |
Narrative objectives1 | The aim is this study is to evaluate the efficacy of prophylactic hemostasis post endoscopic submucosal dissection for early gastric cancer |
Basic objectives2 | Efficacy |
Basic objectives -Others | |
Trial characteristics_1 | |
Trial characteristics_2 | |
Developmental phase |
Assessment | |
Primary outcomes | Retio of delayed bleeding(hematemesis or melena required endoscopic hemostasis, decreased the hemoglobin count by more than 2g/dl) |
Key secondary outcomes |
Base | |
Study type | Interventional |
Study design | |
Basic design | Parallel |
Randomization | Randomized |
Randomization unit | |
Blinding | Single blind -participants are blinded |
Control | No treatment |
Stratification | |
Dynamic allocation | |
Institution consideration | |
Blocking | |
Concealment |
Intervention | ||
No. of arms | 2 | |
Purpose of intervention | Treatment | |
Type of intervention |
|
|
Interventions/Control_1 | Endoscopic submucosal dissection
|
|
Interventions/Control_2 | coagulation | |
Interventions/Control_3 | ||
Interventions/Control_4 | ||
Interventions/Control_5 | ||
Interventions/Control_6 | ||
Interventions/Control_7 | ||
Interventions/Control_8 | ||
Interventions/Control_9 | ||
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Male and Female | |||
Key inclusion criteria | Patients who were diagnosed as early gastric cancer or gastric adenoma and are considered as the indication of endoscopic submucosal dissection.
Patients who understand the study contents and give informed consents by themselves |
|||
Key exclusion criteria | 1.Patient with major organ failure(heart failure,renal failure,liver failure, Respiratory failure)
2, Patients who have anticoagulant or antiplatelet therapy and who cannot stop it. 3.Patient with Pacer planting 4. Patients who were judged inappropriate by their physicians. |
|||
Target sample size | 260 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | Osaka City University Graduate School of Medicine, Osaka, Japan
|
||||||
Division name | Department of Gastroenterology | ||||||
Zip code | |||||||
Address | Asahimachi abenoku oosaka citu | ||||||
TEL | |||||||
Public contact | |||||||
Name of contact person |
|
||||||
Organization | Osaka City University Graduate School of Medicine, Osaka, Japan | ||||||
Division name | Department of Gastroenterology | ||||||
Zip code | |||||||
Address | |||||||
TEL | |||||||
Homepage URL | |||||||
Sponsor | |
Institute | School of Medicine, Osaka, Japan |
Institute | |
Department |
Funding Source | |
Organization | School of Medicine, Osaka, Japan |
Organization | |
Division | |
Category of Funding Organization | Self funding |
Nationality of Funding Organization |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | |
Address | |
Tel | |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Unpublished |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | No longer recruiting | ||||||
Date of protocol fixation |
|
||||||
Date of IRB | |||||||
Anticipated trial start date |
|
||||||
Last follow-up date | |||||||
Date of closure to data entry | |||||||
Date trial data considered complete | |||||||
Date analysis concluded |
Other | |
Other related information |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005253 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |